ShellySLoMD

Oncology • Chicago, IL

Breast Cancer, Hospice & Palliative

Professor, Medicine, RUSH MD Anderson Cancer Center

Join to view full profile

Dr. Lo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lo's full profile

Already have an account?

Office
1725 W Harrison St
suite 809
Chicago, IL 60612
Phone+1 708-216-3304

Fax+1 708-216-1259

Education & Training

UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2002 - 2004
Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 2001 - 2002
Albany Medical CenterResidency, Internal Medicine/Pediatrics, 1997 - 2001
SUNY Upstate Medical UniversityClass of 1997

Certifications & Licensure

IL State Medical License 2004 - 2026
PA State Medical License 2002 - 2004
American Board of Internal Medicine Hospice and Palliative Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer Start of enrollment: 2007 Oct 01
Completed
Phase 2
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
Active, not recruiting
Phase 3
A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Start of enrollment: 2010 Aug 13
Completed
Phase 3
Phase 2 Study to Assess the Efficacy & Safety of Gemcitabine + Nab Paclitaxel With or Without Dociparstat in Metastatic Pancreatic Cancer Patients Start of enrollment: 2011 Nov 01
Terminated
Phase 2
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score Start of enrollment: 2012 May 01
Completed
PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer Start of enrollment: 2013 May 14
Completed
Phase 2
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer Start of enrollment: 2015 Jul 26
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

Anti-aquaporin-4 immunoglobulin G/anti-myelin oligodendrocyte glycoprotein immunoglobulin G double-positive paraneoplastic neurological syndrome in a patient with trip...
Amna Siddiqui, Dylan Ross, Ronak H Jani, Vikram C Prabhu, Shelly Lo
Clinical & Experimental Neuroimmunology. 2024-02-01
3 citations
Evaluation of the Novel 4R Oncology Care Planning Model in Breast Cancer: Impact on Patient Self-Management and Care Delivery in Safety-Net and Non-Safety-Net Centers.
Julia R. Trosman, Christine B. Weldon, Bruce D. Rapkin, Al B. Benson, Della F. Makower
JCO Oncology Practice. 2021-08-10
8 citations
Outcomes of Specialty Palliative Care Interventions for Patients with Hematologic Malignancies: A Systematic Review.
Elizabeth Elliott, Tracie Watson, Daulath Singh, Wong Connie C, Shelly S. Lo
Journal of Pain and Symptom Management. 2021-03-24

Lectures

Utilization of a web-based supportive oncology training curriculum for healthcare professionals (HCPs).
2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

'It Helps Me Feel Normal': Hospitals Offer Cooling Caps to Help Cancer Patients Preserve HairAugust 3rd, 2018